Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-12-15Clinical Trial Update: Docetaxel/Pemetrexed as 1st Line Treatment in Patients With Non Small Cell Lung Cancer (NSCLC) [Phase 1, Phase 2]
Phase 1/2 trial of first-line docetaxel plus pemetrexed in non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2009-12-09Clinical Trial Update: Pemetrexed/Carboplatin Non-Small Cell Lung Cancer (NSCLC) Elderly Patients [Phase 2]
Phase 2 trial of pemetrexed plus carboplatin in elderly patients with non-small cell lung cancer has completed, with results posted in 2009.
-
CLINICAL_TRIALS trial_result · 2009-12-07Clinical Trial Update: Efficacy Study of GEMOX Combination and Vinorelbine in NSCL Patients [Phase 2]
Phase 2 trial evaluating the efficacy of the GEMOX (gemcitabine and oxaliplatin) combination with vinorelbine in non-small cell lung cancer …
-
CLINICAL_TRIALS trial_result · 2009-12-07Clinical Trial Update: GILT Docetaxel - Non-Small Cell Lung Cancer [Phase 3]
Phase 3 trial update for GILT Docetaxel in non-small cell lung cancer; the study has completed.
-
CLINICAL_TRIALS trial_result · 2009-12-07Clinical Trial Update: Taxotere Combinations as First Line Therapy for Locally Advanced Unresectable or Metastatic Non-small Cell Lung Cancer. [Phase 2]
Phase 2 trial update evaluating Taxotere-based combinations as first-line therapy for locally advanced unresectable or metastatic non-small …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-12-07Clinical Trial Update: ADVANCED Phase II Trial of Weekly vs 3 Weekly Docetaxel and Cisplatin Followed by Gemcitabine in Non-small-cell Lung Cancer (NSCLC) [Phase 2]
A completed Phase II trial comparing weekly versus every-three-week docetaxel and cisplatin, followed by gemcitabine, in non-small cell lung…
-
CLINICAL_TRIALS trial_result · 2009-12-07Clinical Trial Update: Docetaxel in Non Small Cell Lung Cancer (NSCLC) [Phase 2]
Sanofi-sponsored Phase 2 trial evaluating docetaxel for non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2009-12-03Clinical Trial Update: Carboplatin, Gemcitabine, and Thalidomide in Patients Undergoing Surgery for Stage II or III Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial investigating carboplatin, gemcitabine, and thalidomide in patients undergoing surgery for stage II-III non-small cell lung ca…
-
CLINICAL_TRIALS trial_result · 2009-11-25Clinical Trial Update: To Investigate Efficacy and Safety of Pemetrexed as Second or Third Line Therapy in Patients With Non-small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 trial evaluating pemetrexed as second- or third-line therapy for non-small cell lung cancer; the study is completed with results pos…
-
CLINICAL_TRIALS trial_result · 2009-11-23Clinical Trial Update: Non-small Cell Lung Cancer Registry [Phase 4]
A completed Phase 4 registry update for non-small cell lung cancer focusing on malignant pleural effusion.
-
CLINICAL_TRIALS trial_result · 2009-10-30Clinical Trial Update: Low Dose Weekly Docetaxel Versus Pemetrexed in Previously Treated Advanced Non-Small-Cell Lung Cancer [NA]
This completed trial compared low-dose weekly docetaxel versus pemetrexed in previously treated advanced non-small cell lung cancer. The stu…
-
CLINICAL_TRIALS trial_result · 2009-10-12Clinical Trial Update: Dosage Schedule Study of Pemetrexed Monochemotherapy for Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 study evaluating a pemetrexed monotherapy dosing schedule for locally advanced or metastatic non-small cell lung cancer. Results wer…
-
CLINICAL_TRIALS trial_result · 2009-10-12Clinical Trial Update: A Clinical Trial of Vorinostat (MK0683, SAHA) in Combination With FDA Approved Cancer Drugs in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)(0683-056) [Phase 2, Phase 3]
A phase 2/3 trial evaluating vorinostat in combination with approved cancer drugs for advanced non-small cell lung cancer (Stage IIIB/IV) wa…
-
CLINICAL_TRIALS trial_result · 2009-10-08Clinical Trial Update: Phase I/II Trial of Infusional Gemcitabine in Combination With Carboplatin in Chemonaive Non-small Cell Carcinoma [Phase 2]
A Phase I/II trial evaluating infusional gemcitabine in combination with carboplatin in chemo-naive non-small cell lung cancer has completed…
-
CLINICAL_TRIALS trial_result · 2009-10-06Clinical Trial Update: Chemotherapy for Patients With Non-Small Cell Lung Cancer [Phase 4]
Phase 4 clinical trial update evaluating chemotherapy for patients with non-small cell lung cancer; results were posted in 2009.
-
CLINICAL_TRIALS trial_result · 2009-09-28Clinical Trial Update: Randomized Ph 2 Trial Of Paclitaxel/Carboplatin /Bevacizumab + PF-3512676 And P/C/B Alone In Advanced Nonsquamous NSCLC [Phase 2]
A randomized Phase 2 trial evaluated paclitaxel/carboplatin/bevacizumab with PF-3512676 versus paclitaxel/carboplatin/bevacizumab alone in a…
-
CLINICAL_TRIALS trial_result · 2009-09-28Clinical Trial Update: Trial of Pemetrexed With or Without PF-3512676 in Advanced Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating pemetrexed with or without PF-3512676 in advanced non-small cell lung cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2009-09-17Clinical Trial Update: Erlotinib and Sequential Positron Emission Tomography (PET) in Advanced Non Small Cell Lung Cancer (NSCLC) [Phase 2]
A Phase 2 clinical trial update evaluating Erlotinib with sequential PET in advanced non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2009-09-04Clinical Trial Update: Safety and Tolerability of Low-Dose Temozolomide During Whole Brain Radiation in Patients With Cerebral Metastases From Non-Small-Cell Lung Cancer (Study P04071)(TERMINATED) [Phase 2]
A Phase 2 trial evaluating the safety and tolerability of low-dose temozolomide during whole-brain radiation in patients with cerebral metas…
-
CLINICAL_TRIALS trial_result · 2009-09-04Clinical Trial Update: A Study of BMS-663513 in Combination With Chemoradiation in Subjects With Non Small Cell Lung Carcinoma (NSCLC) [Phase 1]
Phase 1 study of BMS-663513 in combination with chemoradiation for non-small cell lung cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2009-08-25Clinical Trial Update: Paclitaxel and Irinotecan in Treating Patients With Advanced Non-small Cell Lung Cancer [Phase 2]
This document reports results from a Phase 2 trial evaluating paclitaxel plus irinotecan in patients with advanced non-small cell lung cance…
-
CLINICAL_TRIALS trial_result · 2009-08-21Clinical Trial Update: Study Evaluating MAC-321 in Non-small Cell Lung Cancer Refractory to Platinum-based Therapy [Phase 2]
A Phase 2 trial evaluating MAC-321 in platinum-refractory non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2009-08-21Clinical Trial Update: Study Evaluating EKB-569 in Advanced Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 study evaluating EKB-569 in advanced non-small cell lung cancer has completed enrollment and the trial status is reported as compl…
-
CLINICAL_TRIALS trial_result · 2009-08-21Clinical Trial Update: A Study of Sunitinib in Combination With Bevacizumab, Carboplatin, and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer (SABRE-L) [Phase 2]
The SABRE-L study tested a combination of sunitinib, bevacizumab, carboplatin, and paclitaxel in advanced non-small cell lung cancer. The Ph…
-
CLINICAL_TRIALS trial_result · 2009-08-03Clinical Trial Update: Phase II Iressa & Carbo/Gem in NSCLC [Phase 2]
Phase II study evaluating Iressa (gefitinib) in combination with carboplatin and gemcitabine for non-small-cell lung cancer has completed an…